TABLE 3.

Estimates of Sensitivity, Specificity, and Likelihood Ratios for the Clinical Predictive Model

ScoreCandidemicNot CandidemicSensitivityCalculated SpecificityLR(+)LR(−)
04288210
147662699%14%1.150.08
279515585%47%1.620.31
377311263%71%2.180.52
482223341%85%2.780.70
55987717%96%4.100.87
  • LR indicates likelihood ratio.

  • * Patients received 1 point for third-generation cephalosporin exposure, 2 points for thrombocytopenia, 2 points for EGA <25 weeks, and 1 point for EGA 25 to 27 weeks.